Bimatoprost, prostamide activity, and conventional drainage.
about
Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamilyIdentification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexesCurrent understanding of conventional outflow dysfunction in glaucomaProstanoid receptor antagonists: development strategies and therapeutic applicationsRecent advances in pharmacotherapy of glaucomaStanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionEffects of prostaglandin analogues on aqueous humor outflow pathways.Endothelin antagonism as an active principle for glaucoma therapyProstamides (prostaglandin-ethanolamides) and their pharmacology.Clinical options for the reduction of elevated intraocular pressureCellular basis for bimatoprost effects on human conventional outflow.Aqueous humor outflow: dynamics and disease.Outflow facility efficacy of five drugs in enucleated porcine eyes by a method of constant-pressure perfusion.Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow PathwaysDifferential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflowUpdate on the mechanism of action of topical prostaglandins for intraocular pressure reduction.Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.Bimatoprost - a review.Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients.Unconventional aqueous humor outflow: A review.Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.The many faces of the trabecular meshwork cell.Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% - an observational switch study.The biodisposition and hypertrichotic effects of bimatoprost in mouse skinRole of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X.Biomechanical, ultrastructural, and electrophysiological characterization of the non-human primate experimental glaucoma model.Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.PHARMACOLOGICAL REGULATION OF OUTFLOW RESISTANCE DISTAL TO SCHLEMM'S CANAL.
P2860
Q24300569-964E9165-7E1B-4FE4-996B-3865C81E4510Q24336682-28DB6DA1-3438-4EEB-9994-5FC1762E8C65Q26991731-2787A738-03A5-4ACB-B512-0AAFA1D0AE38Q33485483-0F529603-9A0D-4AE7-82DD-5777051F2F33Q33521178-4AACA7BA-ECAE-4D61-9671-D000463DE996Q33727601-8EE95963-1BBB-4092-B7FE-6873FFA88665Q34043309-D5DEABD9-2A5C-49E1-99E2-38C5EAA37BB3Q34393424-7850726C-6F97-48FE-AE5D-029311BCF0D1Q34588644-21BE95CE-A2DE-470F-8221-CC31F0C112BDQ34667670-98F78B0C-23AC-425F-92EC-327E81E57BA3Q34708267-F7EF13C7-5C94-40DF-8AFB-D3278227FB3BQ34735244-3919E279-B4A1-493E-9044-223C20B43470Q35608780-717D0E49-B4CA-4AE9-A761-5FC8C337193AQ35870708-3C157637-5A4E-4E68-B21A-E5D2FB89CB15Q35969296-682F306F-4FD6-4B92-B33B-BF1652458C5BQ37035691-4D3AC0A5-7D0C-4B36-BBF6-C32AFE278973Q37336299-E619B78D-4B7F-46FA-A9B3-82AD3CBE1D84Q37452805-C6BC3F98-E9D5-4451-BDBB-58BC7ADD3DE5Q37623833-DB63EEA8-9CA4-44BF-9A33-7371B52B3D6DQ38598695-2E408A8A-7932-4BC2-BF6F-A55E8754D242Q38724447-B4921CE1-1657-41B3-8E5C-46BEFC717714Q38725839-517FDDE6-3DC0-442B-A172-4EC31F20E8EDQ38904598-ABC5301F-FDF8-45A6-8843-269EE184BABFQ41200583-7A839B6D-F329-4464-8723-47DABF5ED5E1Q41250376-3460DA90-B225-43A2-85E2-011FE558F1FCQ42943389-6BFD997A-2437-4157-B1A3-F50BB1EDB8B0Q43225993-699567BA-587F-42B7-9350-0779A06D8717Q44977209-0A6954E8-2B09-4830-B312-FB46C08D6ECAQ45872509-ED8DEC8A-7441-49EB-8814-74F6548F2BF0Q52598356-2C890774-5B11-483E-9F51-1D12BEBD914E
P2860
Bimatoprost, prostamide activity, and conventional drainage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bimatoprost, prostamide activity, and conventional drainage.
@en
Bimatoprost, prostamide activity, and conventional drainage.
@nl
type
label
Bimatoprost, prostamide activity, and conventional drainage.
@en
Bimatoprost, prostamide activity, and conventional drainage.
@nl
prefLabel
Bimatoprost, prostamide activity, and conventional drainage.
@en
Bimatoprost, prostamide activity, and conventional drainage.
@nl
P2093
P2860
P356
P1476
Bimatoprost, prostamide activity, and conventional drainage.
@en
P2093
Alexander B Kharlamb
Clive L Cornell
Craig S Struble
David F Woodward
Hans G Fliri
Jenny W Wang
José L Martos
Kari J Landsverk
Larry A Wheeler
Michael E Garst
P2860
P304
P356
10.1167/IOVS.07-0080
P407
P577
2007-09-01T00:00:00Z